Association between +45T>G adiponectin polymorphism gene and type 2 diabetes mellitus and metabolic syndrome in a Venezuelan population [version 1; peer review: 2 approved, 1 approved with reservations]
| dc.contributor.author | Sánchez, María Patricia | |
| dc.contributor.author | Prieto, Carem | |
| dc.contributor.author | Mujica, Endrina | |
| dc.contributor.author | Vergara, Kendry | |
| dc.contributor.author | Valencia, Enifer | |
| dc.contributor.author | Villalobos, Eudymar | |
| dc.contributor.author | Medina, Mayerlim | |
| dc.contributor.author | Parra, Michael | |
| dc.contributor.author | D'Addosio, Rosanna | |
| dc.contributor.author | Hoedebecke, Kyle | |
| dc.contributor.author | Rodríguez, Johel E. | |
| dc.contributor.author | Bermudez, Valmore | |
| dc.date.accessioned | 2019-07-18T13:41:38Z | |
| dc.date.available | 2019-07-18T13:41:38Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | Background: Adiponectin (ADIPOQ) is a hormone primarily synthesized by adipocytes and encoded by the ADIPOQ gene, which exerts anti-inflammatory, antiatheratogenic and insulin sensitizing functions. It has been shown that its plasma concentrations are decreased in individuals with metabolic syndrome (MS) and type 2 diabetes mellitus (DM2), which could be due to variations in the gene coding for this protein. The aim of this study was to detect the +45 T>G polymorphism of the ADIPOQ gene in subjects with DM2 and MS in Maracaibo municipality, Zulia state, Venezuela. Methods: A total of 90 subjects who attended the Center for Metabolic Endocrine Research "Dr. Félix Gómez" were enrolled for this study, 46 of which had MS-DM2 and 44 of which were healthy control individuals. Genomic DNA was extracted from blood samples and PCR-restriction fragment length polymorphism analysis was carried out for the promoter region of the ADIPOQ gene. Likewise, the +45 T> G polymorphism was identified and correlated with MS and DM2 in the studied population. Results: The most frequent allele in both groups was the T allele, and the predominant genotype was homozygous T/T (79%). Genotypes with heterozygous T/G and G/G homozygous polymorphism were more frequent in the control group than in the MS-DM2 group. Regarding the individuals with T/G and G/G genotypes, statistically significant lower mean values were found for fasting glucose, total cholesterol, triacylglycerides, abdominal circumference, and for the medians of systolic and diastolic blood pressure. Odds ratio were calculated for the presence or absence of MS and DM2. Conclusions: The results suggested that the presence of the G allele exerts a protective effect on the carrier individuals, thus avoiding the appearance of the aforementioned metabolic alterations. | eng |
| dc.identifier.issn | 20461402 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/3568 | |
| dc.language.iso | eng | eng |
| dc.publisher | F1000 Research Ltda | eng |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | eng |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.source | Revista F1000 Research | eng |
| dc.source | Vol. 8 No. 292 (2019) | spa |
| dc.source.uri | https://doi.org/10.12688/f1000research.16890.1 | eng |
| dc.subject | Metabolic syndrome | eng |
| dc.subject | Type 2 diabetes mellitus | eng |
| dc.subject | ADIPOQ gene | eng |
| dc.subject | Polymorphisms | eng |
| dc.subject | DNA | eng |
| dc.title | Association between +45T>G adiponectin polymorphism gene and type 2 diabetes mellitus and metabolic syndrome in a Venezuelan population [version 1; peer review: 2 approved, 1 approved with reservations] | eng |
| dc.type | article | eng |
| dcterms.references | Breitfeld J, Stumvoll M, Kovacs P: Genetics of adiponectin. Biochimie. 2012; 94(10): 2157–63. | eng |
| dcterms.references | Valero P, Souki A, Rodríguez NA, et al.: editors Valmore Bermúdez-Pirela Yaneth Herazo-Beltrán. Aspectos básicos en obesidad. Barranquilla: Ediciones Universidad Simón Bolívar; 2018. | spa |
| dcterms.references | Nigro E, Scudiero O, Monaco ML, et al.: New insight into adiponectin role in obesity and obesity-related diseases. Biomed Res Int. 2014; 2014: 658913. | eng |
| dcterms.references | Fu Y: Adiponectin signaling and metabolic syndrome. Prog Mol Biol Transl Sci. 2014; 121: 293–319. | eng |
| dcterms.references | Elissondo N, Rosso L, Maidana P, et al.: Adiponectin: An adipocytokine with multiple protective functions. 2008. | eng |
| dcterms.references | Alberti KG, Eckel RH, Grundy SM, et al.: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120(16): 1640–5. | eng |
| dcterms.references | Ramírez-Bran DC, Contreras F: Prevalencia del Síndrome Metabólico. 2014. | spa |
| dcterms.references | Alberti KG, Zimmet P, Shaw J, et al.: The metabolic syndrome--a new worldwide definition. Lancet. 2005; 366(9491): 1059–62. | eng |
| dcterms.references | Kaur J: A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014; 2014: 943162. | eng |
| dcterms.references | Bermudez V, Toledo A, Leal N, et al.: Prevalencia del síndrome metabólico en la población adulta Añú de la laguna de Sinamaica del municipio Páez, estado Zulia. 2009. | spa |
| dcterms.references | Rojas J, Bermúdez V, Añez R, et al.: Comportamiento Epidemiológico del síndrome metabólico en el municipio Maracaibo-Venezuela. Sindrome Cardiometebólico. 2013; 3(2). | spa |
| dcterms.references | Bermudez V, Salazar J, Rojas J, et al.: Prevalencia de diabetes mellitus tipo 2 y factores asociados en la ciudad de Maracaibo, Venezuela. Revista Latinoamericana de Hipertensión. 2014; 9(2): 14–25. | spa |
| dcterms.references | Whiting DR, Guariguata L, Weil C, et al.: IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011; 94(3): 311–21. | eng |
| dcterms.references | OMS: Estadísticas Mundiales 2014. 2014. Report No.: 978924069269. | spa |
| dcterms.references | OMS: Obesidad y sobrepeso. 2015 [cited 2015 22 de noviembre]. | spa |
| dcterms.references | Melistas L, Mantzoros CS, Kontogianni M, et al.: Association of the +45T>G and +276G>T polymorphisms in the adiponectin gene with insulin resistance in nondiabetic Greek women. Eur J Endocrinol. 2009; 161(6): 845–52. | eng |
| dcterms.references | Viso M, Porrello B, Rauseo D, et al.: Adiponectina y su relación con obesidad, insulinorresistencia y síndrome metabólico en adultos de la cohorte cdc de canarias en Venezuela. Rev Venez Endocrinol Metab. 2013; 11(2): 76–86. | spa |
| dcterms.references | Potapov VA, Chistiakov DA, Dubinina A, et al.: Adiponectin and adiponectin receptor gene variants in relation to type 2 diabetes and insulin resistancerelated phenotypes. Rev Diabet Stud. 2008; 5(1): 28–37. | eng |
| dcterms.references | Orellana G, Sapunar J, Sáez K, et al.: Asociación entre polimorfismos del gen de adiponectina y estado nutricional en escolares de la comuna de Hualpén. Rev méd Chile. 2012; 140(10): 1245–52. | spa |
| dcterms.references | Hara K, Horikoshi M, Yamauchi T, et al.: Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care. 2006; 29(6): 1357–62. | eng |
| dcterms.references | Kishida K, Funahashi T, Shimomura I: Adiponectin as a routine clinical biomarker. Best Pract Res Clin Endocrinol Metab. 2014; 28(1): 119–30. | eng |
| dcterms.references | American Diabetes Association: (2) Classification and diagnosis of diabetes. Diabetes Care. 2015; 38 Suppl: S8–S16. | eng |
| dcterms.references | Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research. 1988; 16(3): 1215. | eng |
| dcterms.references | Krízová J, Dolinková M, Lacinová Z, et al.: Adiponectin and resistin gene polymorphisms in patients with anorexia nervosa and obesity and its influence on metabolic phenotype. Physiol Res. 2008; 57(4): 539–46. | eng |
| dcterms.references | Hoedebecke K: Association between +45T>G adiponectin polymorphism gene and type 2 diabetes mellitus and metabolic syndrome in a Venezuelan Population. 2019. | eng |
| dcterms.references | Vendramini MF, Pereira AC, Ferreira SR, et al.: Association of genetic variants in the adiponectin encoding gene (ADIPOQ) with type 2 diabetes in Japanese Brazilians. J Diabetes Complications. 2010; 24(2): 115–20. | eng |
| dcterms.references | Saxena M, Srivastava N, Banerjee M: Genetic association of adiponectin gene polymorphisms (+45T/G and +10211T/G) with type 2 diabetes in North Indians. Diabetes Metab Syndr. 2012; 6(2): 65–9. | eng |
| dcterms.references | Sahli S, Khlifi L, Jaballah A, et al.: Evaluation of serum adiponectin and ADIPOQ +45 T>G polymorphism with metabolic syndrome in tunisian population. IJPSR. 2017; 8(3): 1294–3000. | eng |
| dcterms.references | Du W, Li Q, Lu Y, et al.: Genetic variants in ADIPOQ gene and the risk of type 2 diabetes: a case-control study of Chinese Han population. Endocrine. 2011; 40(3): 413–22. | eng |
| dcterms.references | Esteghamati A, Mansournia N, Nakhjavani M, et al.: Association of +45(T/G) and +276(G/T) polymorphisms in the adiponectin gene with coronary artery disease in a population of Iranian patients with type 2 diabetes. Mol Biol Rep. 2012; 39(4): 3791–7. | eng |
| dcterms.references | Al Hannan FA, O'Farrell PA, Morgan MP, et al.: Associations between singlenucleotide polymorphisms of ADIPOQ, serum adiponectin and increased type 2 diabetes mellitus risk in Bahraini individuals. East Mediterr Health J. 2016; 22(8): 611–8. | eng |
| dcterms.references | Menzaghi C, Ercolino T, Di Paola R, et al.: A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes. 2002; 51(7): 2306–12. | eng |
| dcterms.references | Yang WS, Tsou PL, Lee WJ, et al.: Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity. J Mol Med (Berl). 2003; 81(7): 428–34. | eng |
| dcterms.references | Matharoo K, Arora P, Bhanwer AJ: Association of adiponectin (AdipoQ) and sulphonylurea receptor (ABCC8) gene polymorphisms with Type 2 Diabetes in North Indian population of Punjab. Gene. 2013; 527(1): 228–34. | eng |
| dcterms.references | Menzaghi C, Trischitta V, Doria A: Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes. 2007; 56(5): 1198–209. | eng |
| dcterms.references | Stumvoll M, Tschritter O, Fritsche A, et al.: Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes. 2002; 51(1): 37–41. | eng |
| dcterms.references | Lee YY, Lee NS, Cho YM, et al.: Genetic association study of adiponectin polymorphisms with risk of Type 2 diabetes mellitus in Korean population. Diabet Med. 2005; 22(5): 569–75. | eng |
| dcterms.references | Li X, Wei D, He H, et al.: Association of the adiponectin gene (ADIPOQ) +45 T > G polymorphism with the metabolic syndrome among Han Chinese in Sichuan province of China. Asia Pac J Clin Nutr. 2012; 21(2): 296–301. | eng |
| dcterms.references | Ukkola O, Ravussin E, Jacobson P, et al.: Mutations in the adiponectin gene in lean and obese subjects from the Swedish obese subjects cohort. Metabolism. 2003; 52(7): 881–4. | eng |